Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: The Effects of a Jump Rope Exercise Program on Vascular Health, Inflammatory Markers in Prehypertensive Adolescent Girls [NA]
Completed clinical trial evaluating a jump rope exercise program on vascular health and inflammatory markers in prehypertensive adolescent g…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension [NA]
Completed clinical trial investigating renal stent placement for renal artery stenosis in patients with resistant hypertension; results post…
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002) [Phase 1]
Phase 1 study evaluating safety, tolerability, PK and PD of MK8266 in hypertensive men has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED) [Phase 1]
Phase 1 trial of a single-dose MK-3614 has completed; results have been posted.
-
FDA label_change · 2019-08-07FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Bisoprolol Fumarate by Unichem Pharmaceuticals (USA), Inc., resulting in a labeling change for t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-07FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the generic combination product irbesartan and hydrochlorothiazide from Hikma Pharmaceuticals US…
-
FDA approval · 2019-08-07FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approves a supplemental application for enalapril maleate by Taro Pharmaceuticals U.S.A., Inc., pertaining to an approved product (gener…
-
FDA approval · 2019-08-06FDA Approved: CHLORTHALIDONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for chlorthalidone from Unichem Pharmaceuticals (USA), Inc., enabling a generic version of the diureti…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial exploring the relationship between homocysteine levels and contrast-induced nephropathy in hypertensive…
-
FDA approval · 2019-08-05FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for spironolactone, enabling the marketing of a new generic product.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia [Phase 4]
A Phase 4 trial comparing suvorexant to placebo for sleep pressure in hypertensive patients with insomnia has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Taekwondo Training and Postmenopausal Women With Stage-2 Hypertension [NA]
A completed clinical trial investigating Taekwondo training effects in postmenopausal women with stage-2 hypertension; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: A Multi-center Trial of IMPaCT CHW Support for Chronically-ill Patients [NA]
A multi-center trial evaluating IMPaCT Community Health Worker support for chronically ill patients has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: The Effects of Swimming on Elderly Women With Stage-2 Hypertension [NA]
A completed clinical trial evaluating the effects of swimming on elderly women with stage-2 hypertension, with results posted in 2019.
-
FDA approval · 2019-07-30FDA Approved: GUANFACINE — Supplemental Application (Sun Pharmaceutical Industries, Inc)
The FDA approved a supplemental application for guanfacine from Sun Pharmaceutical Industries, Inc., finalizing an updated approval for the …
-
FDA approval · 2019-07-25FDA Approved: SPIRONOLACTONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for spironolactone submitted by Sun Pharmaceutical Industries, Inc., indicating an update to the…
-
FDA approval · 2019-07-18FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Lifestar Pharma LLC)
FDA approved an original-application (ANDA) for olmesartan medoxomil from Lifestar Pharma LLC, expanding generic availability for hypertensi…
-
FDA approval · 2019-07-12FDA Approved: ETHACRYNIC ACID — Original Application (TRUPHARMA LLC)
FDA approves the original ANDA for Ethacrynic acid by Trupharma LLC, enabling its generic distribution as a loop diuretic. The approval cove…
-
FDA approval · 2019-07-09FDA Approved: TELMISARTAN — Supplemental Application (Ascend Laboratories, LLC)
FDA approves a supplemental application for telmisartan from Ascend Laboratories, LLC, authorizing continued marketing of the generic ARB.
-
FDA approval · 2019-07-08FDA Approved: KATERZIA — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approves KATERZIA (amlodipine) through an Original Application by Azurity Pharmaceuticals, introducing an amlodipine oral suspension. Th…
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Adrenal Artery Ablation Treats Primary Aldosteronism [Phase 3]
A Phase 3 clinical trial on adrenal artery ablation for treating primary aldosteronism has completed.
-
FDA approval · 2019-07-05FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals' supplemental application for Losartan Potassium and Hydrochlorothiazide, a generic fixed-dose combinat…
-
FDA approval · 2019-07-05FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for Losartan Potassium Tablets, 25 mg, under ANDA201170.
-
CLINICAL_TRIALS withdrawal · 2019-07-05Clinical Trial Update: Targeting Microvascular Dysfunction in Young Hypertensive Patients [Phase 4]
A Phase 4 clinical trial targeting microvascular dysfunction in young hypertensive patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Rheos Feasibility Trial [Phase 2]
A Phase 2 feasibility trial for Rheos in hypertension has completed.